Recurrent Platinum-sensitive Ovarian Cancer
1 clinical trials · Condition
◉ Watch Recurrent Platinum-sensitive Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer (NCT01837251) | AGO Research GmbH | 2013-05-01 |
Track Recurrent Platinum-sensitive Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.